Magnerot tab. 500mg # 50
Category
Sedatives
,
Neurological disorders
,
Antipsychotics
Scope of the drug
Vitamins
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
fifty
White or off-white round flat tablets with bevels on both sides and a notch on one side.
Name ENG
MAGNEROT
Clinical and pharmacological group
Magnesium preparation
ATX code
Magnesium orotate
Dosage
500mg
Structure
Active ingredient: magnesium orotate dihydrate - 500 mg
Excipients: colloidal silicon dioxide, sodium croscarmellose, microcrystalline cellulose, corn starch, povidone-K30, lactose monohydrate, sodium cyclamate, talc, magnesium stearate.
Indications
Established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as irritability, minor sleep disturbances, gastrointestinal cramps, increased fatigue, muscle pain and spasms, tingling sensation in the muscles.
If after a month of treatment there is no decrease in these symptoms, continued treatment is impractical.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 5 years
INN / Active ingredient
magnesium orotate dihydrate
Contraindications
Hypersensitivity to the components of the drug, urolithiasis, renal dysfunction, predisposition to the formation of calcium-magnesium-ammonium-phosphate stones, myasthenia gravis, atrioventricular block, cirrhosis of the liver with ascites, children under 18 years of age, lactose intolerance, lactase or glucose deficiency galactose malabsorption (due to the presence of lactose in the composition).
Specifications
Category
Sedatives
,
Neurological disorders
,
Antipsychotics
Scope of the drug
Vitamins
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
fifty
Minimum age from
18 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Vervag Pharma
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Magnesium drug
Anatomical and therapeutic characteristics
A12CC09 Magnesium orotate
Dosage form
Pills
Expiration date in days
1826
Dosage (volume) of the substance in the preparation
1 tablet contains: magnesium orotate dihydrate 500 mg
The target audience
Adult
Package weight, g
thirty
Mode of application
:
The tablets are taken orally before meals with a little water.
2 tablets 3 times a day for 7 days, then 1 tablet 2-3 times a day daily.
The duration of the course of treatment is 4 weeks.
Treatment should be discontinued immediately after the normalization of the concentration of magnesium in the blood.